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weight was associated with an elevated risk among premenopausal
women (OR¼1.7, 95% CI 1.1–2.5), but a nonsignificantly
reduced risk among postmenopausal women (OR¼0.6, 95% CI
0.3–1.1) (Sanderson et al, 1996). Therefore, IGF-I as a potential
explanation for the birth weight-breast cancer relationship cannot
be ruled out.
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Sir,
We welcome the comments of van Noord concerning the different
results for birth weight and breast cancer risk reported by
ourselves (Vatten et al, 2002) and Sanderson et al (2002). He
suggests that women’s breast cancer risk is influenced by the
preconception viability of their mothers’ oocytes, particularly the
quality of their mitochondria, since mitochondrial quality declines
with age. Therefore, van Noord proposes that maternal age at birth
is positively associated with breast cancer risk, suggesting that we
reanalyse our data to test this hypothesis.
Reliable information on maternal age at birth was available in
the Trondheim data, and hence this analysis is based on 186 breast
cancer cases and 662 age-matched controls. We used conditional
logistic regression to explore the association between the risk of
breast cancer and maternal age at birth, and the estimated odds
ratios are adjusted for age at first birth and parity. As shown in
Table 1, we found no association with breast cancer risk over the
four categories of maternal age at birth.
Although van Noord has proposed an interesting hypothesis, we
found no evidence to support that maternal age at birth is
positively associated with breast cancer risk. In light of our
original findings, that both birth weight and birth length are
positively associated with breast cancer risk, important mechan-
isms linking birth characteristics to breast cancer may be related to
foetal growth. Recent research has shown that both birth weight
and maternal pre-eclampsia are associated with adolescent growth
and maturation (Vatten et al, 2003), and therefore, the intrauterine
environment may initiate a tracking pattern of growth that ranges
throughout childhood and adolescence. Ultimately, this may play a
critical role in the development of breast cancer.
Table 1 Odds ratios (ORs) and 95% confidence intervals (CIs) of breast
cancer associated with maternal age at birth
Variable
Case
patients
Control
subjects OR
ab 95% CI
Maternal age at birth
o25 56 196 1.0 Reference
25–29 60 212 1.0 0.7–1.5
30–34 41 155 1.0 0.6–1.5
X35 29 99 1.0 1.6–1.6
P trend¼0.97
aORs are computed using conditional logistic regression with cases and controls
matched on year of birth.
bORs are adjusted for age at first birth and parity in the
regression model.
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